Literature DB >> 30735228

Potential Excessive Testing at Scale: Biomarkers, Genomics, and Machine Learning.

Kenneth D Mandl1,2, Arjun K Manrai1,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30735228      PMCID： PMC7572222          DOI： 10.1001/jama.2019.0286

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  5 in total

1.  Cancer Screening, Overdiagnosis, and Regulatory Capture.

Authors:  H Gilbert Welch
Journal:  JAMA Intern Med       Date:  2017-07-01       Impact factor: 21.873

2.  The Medicalization of Common Conditions.

Authors:  Rita F Redberg
Journal:  JAMA Intern Med       Date:  2016-12-01       Impact factor: 21.873

3.  Direct-to-Consumer Genetic Testing: The Implications of the US FDA's First Marketing Authorization for BRCA Mutation Testing.

Authors:  Jennifer Gill; Adam J Obley; Vinay Prasad
Journal:  JAMA       Date:  2018-06-19       Impact factor: 56.272

4.  Application of new cholesterol guidelines to a population-based sample.

Authors:  Michael J Pencina; Ann Marie Navar-Boggan; Ralph B D'Agostino; Ken Williams; Benjamin Neely; Allan D Sniderman; Eric D Peterson
Journal:  N Engl J Med       Date:  2014-03-19       Impact factor: 91.245

5.  Medical Marketing in the United States, 1997-2016.

Authors:  Lisa M Schwartz; Steven Woloshin
Journal:  JAMA       Date:  2019-01-01       Impact factor: 56.272
  5 in total
  9 in total

1.  Non-Parametric Combined Reference Regions and Prediction of Clinical Risk.

Authors:  Roy Malka; Carlo Brugnara; Ron Cialic; John M Higgins
Journal:  Clin Chem       Date:  2020-02-01       Impact factor: 8.327

Review 2.  Digital Biomarkers in Psychiatric Research: Data Protection Qualifications in a Complex Ecosystem.

Authors:  Andrea Parziale; Deborah Mascalzoni
Journal:  Front Psychiatry       Date:  2022-06-09       Impact factor: 5.435

3.  Studying human-AI collaboration protocols: the case of the Kasparov's law in radiological double reading.

Authors:  Federico Cabitza; Andrea Campagner; Luca Maria Sconfienza
Journal:  Health Inf Sci Syst       Date:  2021-02-05

4.  Ethical Issues of Digital Twins for Personalized Health Care Service: Preliminary Mapping Study.

Authors:  Pei-Hua Huang; Ki-Hun Kim; Maartje Schermer
Journal:  J Med Internet Res       Date:  2022-01-31       Impact factor: 5.428

Review 5.  Creative Approaches for Assessing Long-term Outcomes in Children.

Authors:  Ann Chen Wu; Corina Graif; Shannon Gwin Mitchell; John Meurer; Kenneth D Mandl
Journal:  Pediatrics       Date:  2021-07       Impact factor: 9.703

Review 6.  Scientific challenges for precision public health.

Authors:  Frank Kee; David Taylor-Robinson
Journal:  J Epidemiol Community Health       Date:  2020-01-23       Impact factor: 3.710

7.  RNA-sequencing reveals that STRN, ZNF484 and WNK1 add to the value of mitochondrial MT-COI and COX10 as markers of unstable coronary artery disease.

Authors:  Paul Holvoet; Bernward Klocke; Maarten Vanhaverbeke; Roxane Menten; Peter Sinnaeve; Emma Raitoharju; Terho Lehtimäki; Niku Oksala; Christian Zinser; Stefan Janssens; Karin Sipido; Leo-Pekka Lyytikainen; Stefano Cagnin
Journal:  PLoS One       Date:  2019-12-10       Impact factor: 3.240

8.  Are we ready for artificial intelligence health monitoring in elder care?

Authors:  Anita Ho
Journal:  BMC Geriatr       Date:  2020-09-21       Impact factor: 3.921

9.  Teasing out Artificial Intelligence in Medicine: An Ethical Critique of Artificial Intelligence and Machine Learning in Medicine.

Authors:  Mark Henderson Arnold
Journal:  J Bioeth Inq       Date:  2021-01-07       Impact factor: 2.216
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.